Optimizing Gait Symmetry After Stroke Using Mechanical Constraints and Sensory Feedback
Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Jul 18, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new way to help people who have had a stroke walk more evenly by using special treadmills and feedback tools. The study looks at how adding gentle resistance and real-time signals, like sounds or visuals, can improve the strength and movement of the weaker leg. The goal is to find the best combination of these techniques to help stroke survivors walk more smoothly and safely.
The study will include 15 people who have had a stroke at least one month ago and can walk at least 10 meters (about 30 feet), with or without help, as well as 15 healthy adults who can walk on their own. Each participant will spend about two hours walking on different treadmills while experiencing various resistance and feedback settings. The equipment is safe and non-invasive, and the risk is very low. This is a single-session study, meaning participants will only need to attend once. If you or a loved one fits these criteria and is interested, this trial might offer a chance to try new ways to improve walking after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 20 years or older
- • For stroke group: clinical diagnosis of stroke at least 1 month prior to participation
- • Ability to walk at least 10 meters with or without assistive devices
- • For healthy group: able to walk independently without assistive devices
- Exclusion Criteria:
- • Life expectancy less than one year
- • Comatose or unable to follow three-step commands
- • Amputation of any lower limb
- • Poorly controlled diabetes (e.g., foot ulceration)
- • Blindness
- • Progressive neurological disease
- • Medically unstable condition
- • Significant musculoskeletal impairments affecting gait
- • Congestive heart failure or unstable angina
- • Peripheral vascular disease
- • Severe neuropsychiatric conditions (e.g., dementia, cognitive deficits, severe depression)
About The University Of Texas Medical Branch, Galveston
The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Galveston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported